Papers

7

Total Citations

148

H-Index

5

About

Ton A. Roeleveld is a leading urologic surgeon and researcher whose work centers on improving the diagnosis and treatment of prostate cancer, with a particular focus on precision imaging and surgical outcomes. His most impactful contribution is the landmark SALT trial (106 citations), which demonstrated the superior accuracy of 18F-DCFPyL PSMA PET/CT over conventional imaging for detecting pelvic lymph-node metastases prior to radical prostatectomy—a finding that has reshaped preoperative staging protocols. Roeleveld has also pioneered the use of 3D MRI-based prostate models to predict extraprostatic extension and guide nerve-sparing surgery, enhancing both oncologic control and functional preservation. His research extends to intraoperative care, where he has investigated strategies to reduce catheter-related bladder discomfort, and to postoperative management, including novel treatments for vesico-urethral anastomosis strictures. More recently, he has explored image-guided surgical navigation with electromagnetic tracking for robot-assisted sentinel node biopsy, pushing the boundaries of minimally invasive precision surgery. With a growing portfolio of high-impact studies, Roeleveld is recognized for translating advanced imaging and navigation technologies into tangible improvements in prostate cancer surgery and patient quality of life.

Research Focus

Key Achievements

5
H-Index
7
Papers
148
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
Pelvic lymph-node staging with 18F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial -
106 citations · 2020
📈 Most Prolific Year: 2022 (3 Papers)
🤝 Key Collaborators: 42
🏛 Institutions: Noordwest Ziekenhuisgroep, Northwest Hospital, Amsterdam UMC Location VUmc

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago